Pured red cell aplasia as a presentig form of systemic lupus erythmatosus

  • José I. Martín-Serradilla Palencia University Assistance Complex, Castilla y León Regional Health Management (SACYL), Palencia, Spain
  • Francisco Javier Del Castillo Tirados Palencia University Assistance Complex, Castilla y León Regional Health Management (SACYL), Palencia, Spain
  • María Álvarez De Buergo Segovia Assistance Complex, Castilla y León Regional Health Management (SACYL), Segovia, Spain
  • José M. Alonso Alonso Palencia University Assistance Complex, Castilla y León Regional Health Management (SACYL), Palencia, Spain
  • Fernando Sánchez Barranco Palencia University Assistance Complex, Castilla y León Regional Health Management (SACYL), Palencia, Spain
  • Elisa Álvarez Artero Palencia University Assistance Complex, Castilla y León Regional Health Management (SACYL), Palencia, Spain
Keywords: pure red cell aplasia, systemic lupus erythematosus, corticosteroids

Abstract

Pure red cell aplasia (PRCA) is a syndrome defined by normocytic normochromic anemia with severe reticulocytopenia and marked reduction or absence of erythroid precursors from the bone marrow. Occasionally it is triggered in the course of collagen or autoimmune diseases. We present the first case reported in the literature of a man with PRCA as the onset form of systemic lupus erythematosus (SLE). A 65-year-old man, who presented normocytic normochromic anemia, ANA 1/5120 and anti-Sm 2.61. He reported oral ulcers, polyarthralgia, swelling of both ankles and photosensitivity. Bone marrow examination showed red cell line hypoplasia due to maturation arrest at the level of the basophilic erythroblast, almost absence of mature cells, and a very high content of large proerythroblasts. With the diagnosis of PRCA as the first manifestation of SLE, he was successfully treated with Prednisone. We can conclude that screening for systemic diseases in patients with PRCA is essential to ensure correct management and a better prognosis.

Author Biographies

José I. Martín-Serradilla, Palencia University Assistance Complex, Castilla y León Regional Health Management (SACYL), Palencia, Spain
Rapid Diagnosis Unit, Internal Medicine Service, Palencia University Assistance Complex, SACYL, Palencia
Francisco Javier Del Castillo Tirados, Palencia University Assistance Complex, Castilla y León Regional Health Management (SACYL), Palencia, Spain
Internal Medicine Service, Palencia University Assistance Complex, SACYL, Palencia
María Álvarez De Buergo, Segovia Assistance Complex, Castilla y León Regional Health Management (SACYL), Segovia, Spain
Rheumatology Section, Segovia Assistance Complex, SACYL, Segovia
José M. Alonso Alonso, Palencia University Assistance Complex, Castilla y León Regional Health Management (SACYL), Palencia, Spain
Hematology Service, Palencia University Assistance Complex, SACYL, Palencia
Fernando Sánchez Barranco, Palencia University Assistance Complex, Castilla y León Regional Health Management (SACYL), Palencia, Spain
Internal Medicine Service, Palencia University Assistance Complex, SACYL, Palencia
Elisa Álvarez Artero, Palencia University Assistance Complex, Castilla y León Regional Health Management (SACYL), Palencia, Spain
Internal Medicine Service, Palencia University Assistance Complex, SACYL, Palencia

References

I. Means RT Jr. Pure red cell aplasia. Blood 2016 Nov 24;128(21):2504-2509. doi: 10.1182/blood-2016-05-717140.

II. Habib GS, Saliba WR, Froom P. Pure red cell aplasia and lupus. Semin Arthritis Rheum 2002 Feb;31(4):279-83. doi: 10.1053/sarh.2002.30440.

III. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology. Classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 2019 Sep;71(9):1400-1412. doi: 10.1002/art.40930.

IV. Ahmed SA, Farha MA, Rashed LA, Hamaad M. Pathogenic role of érythropoïétine in Egyptian systemic lupus erthymatosus anemic patients. Prevalence of different types of anemia in SLE. Rev Colomb Reumatol 2019;26(3):151-9.

V. Heck LW, Alarcón GS, Ball GV, et al. Pure red cell aplasia and protein-losing enteropathy in a patient with systemic lupus erythematosus. Arthritis Rheum 1985 Sep;28(9):1059-61. doi: 10.1002/art.1780280914.

VI. Franzén P, Friman C, Pettersson T, Fyhrquist F, Ruutu T. Combined pure red cell aplasia and primary autoimmune hypothyroidism in systemic lupus erythematosus. Arthritis Rheum 1987 Jul;30(7):839-40. doi: 10.1002/art.1780300720.

VII. Yamauchi K, Arimori S. Effective methylprednisolone “pulse” therapy in myeloerythroid aplasia associated with systemic lupus erythematosus: case report and literature review. Tokai J Exp Clin Med 1987 Dec;12(5-6):337-41.

VIII. Barba-Romero MA, Moreno-Merino M, Medrano-González F, Puras-Tellaeche A. Pure red cell aplasia associated with systemic lupus erythematosus. An Med Int 1992 Jun;9(6):311-2.

IX. Kiely PD, McGuckin CP, Collins DA, Bevan DH, Marsh JC. Erythrocyte aplasia and systemic lupus erythematosus. Lupus 1995 Oct;4(5):407-11. doi: 10.1177/096120339500400512.

X. Linardaki GD, Boki KA, Fertakis A, Tzioufas AG. Pure red cell aplasia as presentation of systemic lupus erythematosus: antibodies to erythropoietin. Scand J Rheumatol 1999;28(3):189-91. doi: 10.1080/03009749950154293.

XI. Duarte-Salazar C, Cazarín-Barrientos J, Goycochea-Robles MV, Collazo-Jaloma J, Burgos-Vargas R. Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A. Rheumatology (Oxford) 2000 Oct;39(10):1155-7. doi: 10.1093/rheumatology/39.10.1155.

XII. Jimeno-Sainz A, Blázquez-Encinar JC, Conesa V. Pure red aplasia as the first manifestation of systemic lupus erythematosus. Am J Med 2001 Jul;111(1):78-9. doi: 10.1016/s0002-9343(01)00787-2.

XIII. Mavragani CP, Vlachaki E, Voulgarelis M. Pure red cell aplasia in a Sjögren's syndrome/lupus erythematosus overlap patient. Am J Hematol 2003 Apr;72(4):259-62. doi: 10.1002/ajh.10302.

XIV. Iwadate H, Kobayashi H, Shio K, et al. A case of systemic lupus erythematosus complicated by pure red cell aplasia and idiopathic portal hypertension after thymectomy. Mod Rheumatol 2006;16(2):109-12. doi: 10.1007/s10165-006-0465-7.

XV. Minami R, Izutsu K, Miyamura T, Yamamoto M, Suematsu E. A case of systemic lupus erythematosus accompanied with pure red cell aplasia. Japanese J Clin Immunol 2006;29(3):148-53. doi: 10.2177/jsci.29.148.

XVI. Fallahi S, Akbarian M, Dabiri S. Pure red cell aplasia as a presenting feature in systemic lupus erythematosus and association with thymoma, hypothyroidism and hypoparathyroidism: a case report and literature review. Iran J Allergy Asthma Immunol 2014 Apr;13(2):138-43.

Published
2022-12-19
How to Cite
1.
Martín-Serradilla JI, Del Castillo Tirados FJ, Álvarez De Buergo M, Alonso Alonso JM, Sánchez Barranco F, Álvarez Artero E. Pured red cell aplasia as a presentig form of systemic lupus erythmatosus. Rev. Argent. Reumatol. [Internet]. 2022Dec.19 [cited 2025May10];33(4):244 -247. Available from: https://ojs.reumatologia.org.ar/index.php/revistaSAR/article/view/339